Page last updated: 2024-11-03

rimantadine and Kidney Failure, Chronic

rimantadine has been researched along with Kidney Failure, Chronic in 2 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
"To provide a review of rimantadine, including its antiviral activity, pharmacokinetics, efficacy, adverse effects, drug interactions, and dosage and administration."2.39Rimantadine: a clinical perspective. ( Nahata, MC; Wintermeyer, SM, 1995)
" The plasma half-life (43."1.27Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure. ( Capparelli, EV; Chow, MS; Izard, M; Stevens, RC; Wills, RJ, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wintermeyer, SM1
Nahata, MC1
Capparelli, EV1
Stevens, RC1
Chow, MS1
Izard, M1
Wills, RJ1

Reviews

1 review available for rimantadine and Kidney Failure, Chronic

ArticleYear
Rimantadine: a clinical perspective.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:3

    Topics: Absorption; Amantadine; Controlled Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Comb

1995

Other Studies

1 other study available for rimantadine and Kidney Failure, Chronic

ArticleYear
Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure.
    Clinical pharmacology and therapeutics, 1988, Volume: 43, Issue:5

    Topics: Adamantane; Adult; Aged; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Mi

1988